Balance Sheet Data
Crinetics Pharmaceuticals, Inc. (CRNX)
$32.74
+0.95 (+2.99%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 163.88 | 118.39 | 170.88 | 333.71 | 334.43 | 14,081.15 | 70,857.08 | 356,556.59 | 1,794,211.64 | 9,028,568.03 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 1.58 | 1.38 | 1.83 | 2.03 | 2.42 | 143.11 | 720.13 | 3,623.75 | 18,234.88 | 91,758.87 |
| Account Receivables (%) | ||||||||||
| Inventories | - | -1.38 | -1.83 | 8.07 | -30.77 | -154.81 | -779.02 | -3,920.09 | -19,726.13 | -99,262.91 |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.46 | 5.50 | 5.59 | 8.47 | 6.88 | 444.42 | 2,236.33 | 11,253.35 | 56,627.43 | 284,952.23 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.06 | -0.49 | -0.19 | -0.44 | -1.66 | -20.13 | -101.29 | -509.71 | -2,564.87 | -12,906.58 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.